CADRC Research Featured at International Protein Aggregation Conference
Dr. Diana Acosta Ingram, a Postdoctoral Fellow in the Kraus Lab within the Department of Pathology at Case Western Reserve University, recently presented her research at the Leuven Protein Aggregation Meeting, an international conference that brings together scientists from around the world to share the latest discoveries in protein aggregation and neurodegenerative disease research. Dr. Acosta Ingram's work is part of a broader effort to understand the biological changes associated with Alzheimer's disease and related dementias. The Kraus Lab is led by Dr. Allison Kraus, who leads the CADRC Biomarker Core, helping to advance research focused on identifying and characterizing biomarkers of disease.
The meeting, held September 9-12, 2026, at the VIB-KU Leuven Center for Neuroscience in Leuven, Belgium, hosted approximately 150 scientists. Dr. Acosta Ingram was selected as one of only 17 researchers invited to give an oral presentation, a distinction that reflects the significance of her work and the growing impact of research being conducted by the Kraus Lab and the CADRC.
During her presentation, Dr. Acosta Ingram shared the latest findings from the Kraus Lab's efforts to characterize aggregated proteins that may occur during normal aging and compare them with those associated with disease. Proteins perform essential functions throughout the body, but under certain conditions they can become misfolded and accumulate in abnormal clumps known as aggregates. These protein aggregates are a hallmark of several neurodegenerative diseases, including Alzheimer's disease.
A major focus of this research is tau, a protein that helps maintain the structure and function of nerve cells in the brain. In Alzheimer's disease, tau can become misfolded and accumulate in abnormal forms. The buildup of misfolded tau is closely associated with cognitive decline and is one of the defining pathological features of the disease. Evidence suggests that misfolded tau may begin accumulating years before symptoms appear and can also be found in age-related tau pathologies.

Dr. Acosta Ingram's research seeks to better detect and characterize misfolded tau across the spectrum of normal aging and disease. Understanding how the structure of misfolded tau proteins relates to their effects on the brain may help researchers distinguish age-related changes from those associated with Alzheimer's disease and other neurodegenerative disorders. This work may also support the development of therapies designed to target harmful protein accumulation before significant cognitive decline occurs.
The research presented at the Leuven Protein Aggregation Meeting aligns closely with the goals of the CADRC Biomarker Core, which works to improve our understanding of the biological changes associated with Alzheimer's disease and related dementias. By identifying and characterizing biomarkers linked to disease processes, researchers hope to improve early detection, track disease progression, and support the development of new therapeutic approaches.
Dr. Acosta Ingram's invitation to present at this prestigious international conference highlights the importance of the research being conducted at Case Western Reserve University and through the Cleveland Alzheimer's Disease Research Center. Sharing these findings with the global scientific community helps advance our understanding of Alzheimer's disease and moves the field closer to improved methods for diagnosis, treatment, and prevention.



